- Preliminary 2022 Monjuvi U.S. net product sales of US$ 89.4 million (€ 84.9 million)
- Anticipated 2023 Monjuvi U.S. net product sales in the range of US$ 80 to 95 million
- Preliminary unaudited financial liability from the collaboration with Incyte of approximately € 220 million which represents a reduction of € 360 million
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.